Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Dale Jessop, CTO at Exco InTouch, commented: “We’re thrilled to have reached this milestone, and even more so having used native apps, as this provides the user with device specific natural controls - driving familiarity and ease of use. Currently the most common approach is to use HTML5, which wraps a web app into mobile operating controls, however, this does not enable the layout to be optimized for the device in use, or incorporate natural button configurations and so does not present the best experience for patients. In contrast, our pedigree in developing mobile solutions for clinical and healthcare programs has enabled us to deliver the benefits of native apps in a timely, cost effective manner across all platforms.”
The variety of apps developed for clients by Exco InTouch covers a broad range of therapeutic areas; from cardiovascular and respiratory diseases through to smoking cessation and vaccination programs, utilizing their flexible platform which adapts to individual program needs. The platform enables the integration of medical device data and also lifestyle devices, such as FitBit™, which are increasingly popular in clinical research to provide secondary outcomes data.
The company’s leading approach enables its clients to select their preferred delivery model, offering the flexibility to either provision appropriate devices for the study population, or more significantly to enable BYOD (Bring Your Own Device) in both clinical and commercial programs. This is enabled by proprietary mDNA® technology, which provides sponsors and payers the robust reassurance of protecting Personally Identifiable Information (PII) and maintaining data security even when using the patients’ own devices.
Tim Davis, CEO and founder of Exco InTouch, commented: “We are leading the way in delivering native apps across all three mobile operating platforms, which not only is an achievement for our company, but also another great milestone for the entire clinical industry. There is huge demand in the industry for eCOA providers to deliver user friendly solutions that the patient finds easy to use and accessible. A clinical trial is reliant on timely engagement from its patients and we are delighted to be foremost in improving patients’ user experience.”
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: email@example.com.